PTLA

Portola Pharmaceuticals, Inc. News Headlines

$22.96
*  
0.62
 negative 
2.78%
Get PTLA Alerts
*Delayed - data as of Apr. 16, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PTLA After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Portola's Betrixaban Study Design Published - Analyst Blog
4/15/2014 4:30:01 PM - Zacks.com

Portola Pharma Announces Publication Of Phase 3 APEX Study Design - Quick Facts
4/14/2014 8:17:00 AM - RTT News

EXAS Gets FDA Panel's Thumbs Up, NRX Ropes In Partners, PRPH Breathes Easy
3/27/2014 11:37:00 PM - RTT News

Portola Initiates Phase 2 Study To Evaluate Andexanet Alfa - Quick Facts
3/27/2014 8:20:00 AM - RTT News

CRME Does It Again, HRTX Extends Rally, IsoRay Sparkles, HTBX Warming Up
3/20/2014 12:23:00 AM - RTT News

Portola Initiates Phase 3 Study Of Anticoagulation Antidote Andexanet Alfa
3/19/2014 8:48:00 AM - RTT News

Portola Pharmaceuticals (PTLA) Jumps: Stock Up 8.3% - Tale of the Tape
3/5/2014 9:51:01 AM - Zacks.com

Portola Pharma. To Present At Cowen And Co. Conference; Webcast At 2:10 PM ET
3/3/2014 1:10:00 PM - RTT News

Portola Pharma Q4 Loss Widens - Quick Facts
2/27/2014 7:51:00 PM - RTT News

DXCM Gets FDA Nod, MRK Breathes Easy, Neovasc Takes Heart, VRX Opens Wallet
2/4/2014 4:08:00 AM - RTT News

Portola Pharmaceuticals: A Biotech Company With Plenty Of Room To Grow
10/30/2013 1:18:00 PM - Seeking Alpha

Portola Strengthens On Hopes For Cardiovascular Franchise
10/21/2013 2:46:00 PM - Seeking Alpha

Portola Prices Public Offering - Analyst Blog
10/18/2013 5:07:09 PM - Zacks.com

Data on Portola's Andexanet Alfa - Analyst Blog
10/15/2013 5:30:01 PM - Zacks.com

Update on Portola's Pipeline - Analyst Blog
10/14/2013 1:40:01 PM - Zacks.com

Encouraging Data on Portola's PRT4445 - Analyst Blog
7/9/2013 5:07:12 PM - Zacks.com

Bayer Announces Positive Phase I Data - Analyst Blog
7/8/2013 5:00:01 PM - Zacks.com

Portola Pharmaceuticals: Developing The Novel Therapies In Blood Clot Formation Disorders
7/1/2013 4:01:00 PM - Seeking Alpha

U.S. IPO Recap: IPO Market Continues Torrid Pace With 6 Pricings, 12 New Filers
5/28/2013 2:13:00 PM - Seeking Alpha

Portola Pharmaceuticals prices upsized IPO at $14.50, within the range
5/22/2013 9:33:59 AM - Renaissance Capital

6 New IPOs Scheduled For Week Of May 20
5/20/2013 7:02:00 PM - Seeking Alpha

6 U.S. IPOs Planned For The Week Of May 20
5/20/2013 3:58:00 PM - Seeking Alpha

Portola Pharmaceuticals sets terms for $100 million IPO
5/7/2013 8:47:33 AM - Renaissance Capital